Telix Pharmaceuticals
The Assistant General Counsel, Americas serves as the lead attorney and strategic legal partner for Telix's Phase 3 and go-to-market activities in the Americas region. This role covers the full Phase 3-to-commercial product lifecycle, including FDA labeling, promotional review, healthcare fraud and abuse compliance, market access, and commercial launch readiness. The position requires an experienced life sciences attorney to provide strategic counsel and manage legal matters for the company's largest market.
Headquarters
North Melbourne, Victoria, Australia
Company Size
201-500 employees
Founded
2015
Telix Pharmaceuticals is a global, commercial‑stage biopharmaceutical company developing diagnostic and therapeutic “theranostic” products that use targeted radiation to detect and treat cancer. It advances radiopharmaceuticals through clinical development, regulatory approval, manufacturing and commercialisation to bring imaging agents and targeted therapies to patients. Telix works with the nuclear medicine community and international partners to scale access and improve outcomes. Its stated mission is to help patients with cancer live longer with better quality lives.
TLX DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Telix Pharmaceuticals
Dec 14, 2025
Telix Pharmaceiuticals sees sell-off on back of class actions | ASX:TLX
Nov 13, 2025
Pharma groups rush to calm investor fears over Trump’s tariff hit
Sep 26, 2025
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Telix Pharmaceuticals.
Telix Pharmaceuticals didn’t post a salary, so this is our estimate from similar listings.
11% above the average for this role
The Market Doesn't Like What It Sees From Telix Pharmaceuticals Limited's (ASX:TLX) Revenues Yet As Shares Tumble 26%
Dec 31, 2025
Senior Director, Counsel, Diagnostics & Medical Devices
Eli Lilly and Company
Senior Director, Counsel, Diagnostics & Medical Devices (USA Remote Role)
Eli Lilly and Company
Senior Counsel Attorney (Medical Device/Pharmaceutical)
Baxter International
Brand Attorney — Business Unit Counsel
Eli Lilly and Company
Legal Counsel – Global Commercial
Sazerac Company
Senior Legal Counsel
Sazerac Company